Zobrazeno 1 - 10
of 14
pro vyhledávání: '"MinZhao Lin"'
Autor:
Bo Li, Gengjia Chen, Huihai Zhong, Tan Li, Minzhao Lin, Huiye Wei, Qiaoyun Zhang, Qi Chen, Jinsheng Huang, Xintao Shuai
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-19 (2024)
Abstract Effective treatment against glioma remains challenging nowadays because the protective blood-brain barrier (BBB) impedes drug penetration into brain and the limited efficacy of conventional chemotherapy. While strong positively charged nanop
Externí odkaz:
https://doaj.org/article/3b7ffa4f1d0b446993f33d5a7fd1ce62
Autor:
Yujun Cai, Gengjia Chen, Minzhao Lin, Bo Li, Huihai Zhong, Tan Li, Zecong Xiao, Yong Wang, Xintao Shuai
Publikováno v:
Aggregate, Vol 5, Iss 3, Pp n/a-n/a (2024)
Abstract Nanodrugs capable of aggregating in the tumor microenvironment (TME) have demonstrated great efficiency in improving the therapeutic outcome. Among various approaches, the strategy utilizing electrostatic interaction as a driving force to ac
Externí odkaz:
https://doaj.org/article/0026e649f0024bf1a63cb790aaafe622
Autor:
Bo Li, Yuejun Lin, Gengjia Chen, Mingyue Cai, Huihai Zhong, Zecong Xiao, Minzhao Lin, Tan Li, Yujun Cai, Xintao Shuai, Jie Ren
Publikováno v:
Advanced Science, Vol 10, Iss 33, Pp n/a-n/a (2023)
Abstract The protective blood‐brain barrier (BBB) prevents most therapeutic agents from entering the brain. Currently, focused ultrasound (FUS) is mostly employed to create microbubbles that induce a cavitation effect to open the BBB. However, micr
Externí odkaz:
https://doaj.org/article/b61c6a14d7a44d8babf85f8d2774c836
Autor:
Huihai Zhong, Gengjia Chen, Tan Li, Jinsheng Huang, Minzhao Lin, Bo Li, Zecong Xiao, Xintao Shuai
Publikováno v:
Nano Letters.
Publikováno v:
Science China Chemistry. 65:1383-1400
Autor:
TianCheng Wang, MinZhao Lin, JunJie Mao, LiRong Tian, HaiRun Gan, XinYan Hu, LeYe Yan, HaoYu Long, JianXun Cai, XiaoDi Zheng, YuDong Xiao, Dan Li, XinTao Shuai, PengFei Pang
Publikováno v:
ACS applied materialsinterfaces.
Immune checkpoint blockade (ICB) utilizing programmed death ligand-1 (PD-L1) antibody is a promising treatment strategy in solid tumors. However, in fact, more than half of hepatocellular carcinoma (HCC) patients are unresponsive to PD-L1-based ICB t
Autor:
Jinsheng Huang, Huiling Huang, Yiyao Wang, Bin Xu, Minzhao Lin, Shisong Han, Yuanyuan Yuan, Yong Wang, Xintao Shuai
Publikováno v:
Biomaterials. 299:122134
Autor:
Lijun Hu, Sicong Huang, Gengjia Chen, Bo Li, Tan Li, Minzhao Lin, Yongquan Huang, Zecong Xiao, Xintao Shuai, Zhongzhen Su
Publikováno v:
ACS applied materialsinterfaces. 14(28)
Oxaliplatin (OXA) is a first-line chemotherapeutic agent for treating colorectal cancer (CC). However, the chemotherapeutic effect of OXA on CC is limited by the M2-like polarization of tumor-associated macrophages (TAMs) in the tumor microenvironmen
Publikováno v:
Biomaterials. 296:122067
Autor:
Tan Li, Gengjia Chen, Zecong Xiao, Bo Li, Huihai Zhong, Minzhao Lin, Yujun Cai, Jing Huang, Xi Xie, Xintao Shuai
Publikováno v:
Nano letters. 22(7)
Recent breakthroughs in cell membrane-fabricated nanovaccine offer innovateive therapeutic options for preventing tumor metastasies and recurrence, yet the treatment of patient-specific solid tumor remained challenging owing to the immunosuppressive